Philip Morris International (PM)
(Delayed Data from NYSE)
$120.89 USD
+0.47 (0.39%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $121.00 +0.11 (0.09%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$120.89 USD
+0.47 (0.39%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $121.00 +0.11 (0.09%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Zacks News
Philip Morris (PM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) Gains on Low Risk Tobacco Products & Strong Pricing
by Zacks Equity Research
Altria's (MO) efforts to boost oral tobacco offerings and expansion of IQOS across stores are yielding. Moreover, pricing power is aiding revenue growth.
Why Philip Morris (PM) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will RRPs Growth Keep Driving Philip Morris (PM) in 2021?
by Zacks Equity Research
Philip Morris (PM) is gaining from growing popularity of IQOS, which is boosting revenues in the RRPs category.
Altria (MO) Gains on Low-Risk Products Amid Soft Cigarette Sales
by Zacks Equity Research
Altria (MO) is gaining from the popularity of low-risk tobacco alternatives such as IQOS and on!, as well as prudent pricing strategies.
RRPs Gaining Popularity: 3 Tobacco Stocks to Watch in 2021
by Vidya Nair
Tobacco industry players like PM, MO, and TPB are poised to benefit from rising popularity of low-risk tobacco alternatives. However, low cigarette sales volumes are likely to remain a headwind.
Philip Morris's (PM) IQOS 3 Receives FDA Authorization for Sale
by Zacks Equity Research
FDA approves the sale of Philip Morris's (PM) IQOS devices in the United States. The latest device includes a number of technological advancements compared with its predecessors.
Why Is Philip Morris (PM) Up 4.9% Since Last Earnings Report?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Philip Morris, Lockheed Martin, Advanced Micro Devices, Boeing and General Electric
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Philip Morris, Lockheed Martin, Advanced Micro Devices, Boeing and General Electric
Top Stock Reports for Philip Morris, Lockheed Martin & AMD
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Philip Morris International (PM), Lockheed Martin (LMT) and Advanced Micro Devices (AMD).
Philip Morris (PM) Tops Q3 Earnings Estimates, Raises Guidance
by Zacks Equity Research
Philip Morris' (PM) third-quarter 2020 results reflect solid pricing variance, though soft cigarette volumes hurt revenues and earnings. Management raises earnings per share view for 2020.
Philip Morris (PM) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 4.41% and 2.53%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: PPG, PG, Philip Morris, Northrop and Danaher
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PPG, PG, Philip Morris, Northrop and Danaher
Why Earnings Season Could Be Great for Philip Morris (PM)
by Zacks Equity Research
Philip Morris (PM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
All You Should Know Before Philip Morris' (PM) Q3 Earnings
by Zacks Equity Research
Philip Morris' (PM) third-quarter 2020 results are likely to reflect soft duty-free sales due to the pandemic-led travel restrictions. However, strength in reduced-risk products should aid.
Buy 5 Corporate Giants Ahead of Earnings Results Next Week
by Nalak Das
Five corporate behemoths with a favorable Zacks Rank are poised to beat earnings estimates next week. Investment in these stocks will be fruitful at this stage.
Philip Morris (PM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Philip Morris (PM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Philip Morris (PM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Lamb Weston (LW) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Lamb Weston's (LW) first-quarter fiscal 2021 performance is likely to reflect adverse impacts of low traffic at restaurants amid the pandemic. Also, increased COVID-19 related costs are a concern.
All You Should Know Before Helen of Troy's (HELE) Q2 Earnings
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2021 results are likely to reflect strength in Leadership brands and online sales.
Oral Tobacco Unit Supports Altria Amid Poor Cigarette Sales
by Zacks Equity Research
Altria (MO) is gaining from rising popularity of low risk tobacco alternatives. However the company's smokeable unit is bearing the brunt of soft cigarette sales.
PepsiCo (PEP) to Report Q3 Earnings: Will It Beat Estimates?
by Zacks Equity Research
PepsiCo's (PEP) Q3 results are likely to reflect gains from increased at-home consumption trends and growth in e-commerce, with strong demand for snacks, energy drinks and ready-to-drink coffee.
Here's All You Should Note Before Conagra's (CAG) Q1 Earnings
by Zacks Equity Research
Conagra Brands' (CAG) first-quarter fiscal 2021 results are likely to reflect strength in the retail business, thanks to solid demand stemming from the pandemic-led higher at-home consumption.
All You Need to Note Before McCormick's (MKC) Q3 Earnings
by Zacks Equity Research
McCormick's (MKC) third-quarter fiscal 2020 results are likely to reflect strength in the Consumer Business unit, though the Flavor Solutions unit has been seeing soft pandemic-led demand.
The Zacks Analyst Blog Highlights: AT&T, Philip Morris, Square, Zoom and Vale
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AT&T, Philip Morris, Square, Zoom and Vale